BAKI MEDIC: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BAKI MEDIC
Largest movements
- Receivables within one year -€331,563
down €331,563 (-43.4%), from €763,560 to €431,997
of which Other amounts receivable: -€333,615
- Cash +€73,187
up €73,187 (+48.1%), from €152,117 to €225,304
mainly Receivables within one year (+€331,563) and Net result for the year (+€181,692)
- Tangible fixed assets -€9,628
down €9,628 (-80.2%), from €12,006 to €2,379
of which Land and buildings: -€9,987
- Reserves -€275,300
down €275,300 (-35.3%), from €779,810 to €504,510
- Other debts +€26,665
new in 2025: €26,665
- Tax, wage and social debts -€18,665
down €18,665 (-43.2%), from €43,221 to €24,556
of which Taxes: -€12,553
- Gross operating margin +€12,955
up €12,955 (+5.6%), from €231,564 to €244,519
- Financial income -€10,415
down €10,415 (-24.2%), from €43,005 to €32,590
- Depreciation -€9,821
down €9,821 (-50.2%), from €19,568 to €9,748
- Taxes +€6,743
up €6,743 (+8.9%), from €75,910 to €82,653
- Other operating charges -€2,565
down €2,565 (-86.5%), from €2,964 to €400
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €931,842 | €662,617 | -€269,225 | -28.9% |
| Fixed assets | 21/28 | €12,006 | €2,379 | -€9,628 | -80.2% |
| Tangible fixed assets | 22/27 | €12,006 | €2,379 | -€9,628 | -80.2% |
| Land and buildings | 22 | €9,987 | - | -€9,987 | |
| Furniture and vehicles | 24 | €2,020 | €2,379 | +€359 | +17.8% |
| Current assets | 29/58 | €919,835 | €660,238 | -€259,598 | -28.2% |
| Amounts receivable within one year | 40/41 | €763,560 | €431,997 | -€331,563 | -43.4% |
| Trade receivables | 40 | €71 | €2,123 | +€2,052 | +2,889% |
| Other amounts receivable | 41 | €763,489 | €429,874 | -€333,615 | -43.7% |
| Cash at bank and in hand | 54/58 | €152,117 | €225,304 | +€73,187 | +48.1% |
| Deferred charges and accrued income | 490/1 | €4,158 | €2,937 | -€1,221 | -29.4% |
| Total equity and liabilities | 10/49 | €931,842 | €662,617 | -€269,225 | -28.9% |
| Equity | 10/15 | €884,596 | €609,277 | -€275,319 | -31.1% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €779,810 | €504,510 | -€275,300 | -35.3% |
| Distributable reserves | 133 | €779,810 | €504,510 | -€275,300 | -35.3% |
| Profit (loss) carried forward | 14 | €98,404 | €98,446 | +€42 | 0.0% |
| Investment grants | 15 | €182 | €121 | -€61 | -33.5% |
| Provisions and deferred taxes | 16 | €93 | €61 | -€32 | -34.4% |
| Deferred taxes | 168 | €93 | €61 | -€32 | -34.4% |
| Amounts payable | 17/49 | €47,153 | €53,278 | +€6,126 | +13.0% |
| Amounts payable within one year | 42/48 | €47,123 | €53,278 | +€6,155 | +13.1% |
| Current portion of amounts payable after more than one year | 42 | €1,746 | - | -€1,746 | |
| Trade debts | 44 | €2,156 | €2,057 | -€99 | -4.6% |
| Suppliers | 440/4 | €2,156 | €2,057 | -€99 | -4.6% |
| Taxes, remuneration and social security | 45 | €43,221 | €24,556 | -€18,665 | -43.2% |
| Taxes | 450/3 | €37,110 | €24,556 | -€12,553 | -33.8% |
| Remuneration and social security | 454/9 | €6,112 | - | -€6,112 | |
| Other amounts payable | 47/48 | - | €26,665 | +€26,665 | |
| Accrued charges and deferred income | 492/3 | €29 | - | -€29 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,568 | €9,748 | -€9,821 | -50.2% |
| Other operating charges | 640/8 | €2,964 | €400 | -€2,565 | -86.5% |
| Non-recurring operating charges | 66A | - | €1,609 | +€1,609 | |
| Gross operating margin | 9900 | €231,564 | €244,519 | +€12,955 | +5.6% |
| Operating profit (loss) | 9901 | €209,031 | €232,763 | +€23,732 | +11.4% |
| Financial income | 75/76B | €43,005 | €32,590 | -€10,415 | -24.2% |
| Recurring financial income | 75 | €43,005 | €32,590 | -€10,415 | -24.2% |
| Financial charges | 65/66B | €1,855 | €1,039 | -€816 | -44.0% |
| Recurring financial charges | 65 | €1,855 | €1,039 | -€816 | -44.0% |
| Profit (loss) for the period before taxes | 9903 | €250,181 | €264,314 | +€14,132 | +5.6% |
| Transfer from deferred taxes | 780 | €32 | €32 | = | 0.0% |
| Income taxes | 67/77 | €75,910 | €82,653 | +€6,743 | +8.9% |
| Profit (loss) for the period | 9904 | €174,303 | €181,692 | +€7,389 | +4.2% |
| Profit (loss) for the period to be appropriated | 9905 | €174,303 | €181,692 | +€7,389 | +4.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.